Net profit of Strides Pharma Science rose 77.07% to Rs 87.95 crore in the quarter ended December 2024 as against Rs 49.67 crore during the previous quarter ended December 2023. Sales rose 14.71% to Rs 1153.67 crore in the quarter ended December 2024 as against Rs 1005.77 crore during the previous quarter ended December 2023.
Particulars | Quarter Ended |
| Dec. 2024 | Dec. 2023 | % Var. |
Sales | 1153.67 | 1005.77 | 15 |
OPM % | 18.23 | 12.87 | - |
PBDT | 164.70 | 68.49 | 140 |
PBT | 116.28 | 19.04 | 511 |
NP | 87.95 | 49.67 | 77 |